Total planned funding: $555,714,176
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $108,596,371 |
Mozambique | $75,895,731 |
South Africa | $63,297,913 |
Kenya | $41,654,739 |
Asia Regional Program | $35,475,616 |
Zambia | $27,941,483 |
Ethiopia | $23,028,479 |
Vietnam | $20,590,989 |
Zimbabwe | $18,045,078 |
Burundi | $15,761,257 |
Tanzania | $13,577,589 |
West Africa Region | $13,460,980 |
Democratic Republic of the Congo | $10,148,546 |
Rwanda | $9,393,797 |
Namibia | $8,575,914 |
Malawi | $8,149,263 |
Dominican Republic | $7,751,779 |
Botswana | $7,349,740 |
Côte d'Ivoire | $7,043,572 |
Guyana | $6,620,000 |
enumerations.Philippines | $6,341,584 |
Haiti | $5,899,217 |
Uganda | $5,219,092 |
Lesotho | $4,295,857 |
Eswatini | $4,290,687 |
Papua New Guinea | $3,494,885 |
Angola | $2,250,000 |
Western Hemisphere Region | $709,018 |
India | $600,000 |
Indonesia | $255,000 |
South Sudan | $0 |
Ghana | $0 |
Caribbean Region | $0 |
Organizational Types
NGO | $555,714,176 |
Program Areas
Care | $148,300,939 |
Treatment | $126,199,979 |
Prevention | $97,818,667 |
Testing | $47,336,946 |
Governance and Systems | $32,682,564 |
Budget Codes
HTXS: Treatment: Adult Treatment | $114,354,257 |
HKID: Care: Orphans and Vulnerable Children | $87,554,595 |
HVOP: Sexual Prevention: Other Sexual Prevention | $51,379,121 |
HVCT: Testing: HIV Testing and Counseling | $47,336,946 |
HBHC: Care: Adult Care and Support | $45,001,098 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $17,747,790 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $16,508,366 |
OHSS: Health Systems Strengthening | $11,690,492 |
HLAB: Laboratory Infrastructure | $10,887,394 |
HVSI: Strategic Information | $10,104,678 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $9,921,585 |
HVTB: Care: TB/HIV | $7,915,015 |
PDCS: Care: Pediatric Care and Support | $7,830,231 |
PDTX: Treatment: Pediatric Treatment | $6,763,608 |
HTXD: Treatment: ARV Drugs | $5,082,114 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,712,636 |
HMIN: Biomedical Prevention: Injection Safety | $402,734 |
HMBL: Biomedical Prevention: Blood Safety | $146,435 |